La vacuna Nuvaxovid™ COVID-19 es la primera opción basada en proteinas para adolescentes de 12 a 17 años en Europa GAITHERSBURG, Md., 5 de julio de 2022 /PRNewswire/ — Novavax, Inc. (Nasdaq: NVAX), una empresa de biotecnología dedicada al desarrollo y la comercialización de vacunas de…
Related Posts
Spartech Announces John Alfano as General Manager, Thin Gauge Sheet
ST. LOUIS, Aug. 3, 2022 /PRNewswire/ — Spartech, a leading manufacturer of engineered thermoplastics and custom packaging solutions, is pleased…
Hydronic Underfloor Heating Market to Reach US$ 7.59 Bn by 2032 -Future Market Insights, Inc.
The European hydronic underfloor heating market is expected to be worth more than three and a half billion dollars by…
Vistra Reports PJM Auction Results
IRVING, Texas, June 22, 2022 /PRNewswire/ — Vistra (NYSE: VST) today reported its results from the PJM capacity auction for…